BioRestorative Therapies, Inc. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
BioRestorative Therapies, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q3 2024.
  • BioRestorative Therapies, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 75M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 75M 0 0% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 75M 0 0% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 75M 0 0% Mar 31, 2024 10-Q 2024-06-11
Q4 2023 75M 0 0% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 75M 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 75M 0 0% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 75M 0 0% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 75M 0 0% Dec 31, 2022 10-K/A 2024-06-11
Q3 2022 75M Sep 30, 2022 10-Q 2022-11-14
Q2 2022 75M -300B Jun 30, 2022 10-Q 2022-08-15
Q1 2022 75M -300B Mar 31, 2022 10-Q 2022-05-16
Q4 2021 75M 0 0% Dec 31, 2021 10-K 2023-03-27
Q2 2021 300B* 0 Jun 30, 2021 10-Q 2021-08-16
Q1 2021 300B* 0 Mar 31, 2021 10-Q 2021-05-17
Q4 2020 75M -300B Dec 31, 2020 10-K 2022-03-30
Q3 2020 300B* +300B Sep 30, 2020 10-Q 2021-04-12
Q2 2020 300B* +300B Jun 30, 2020 10-Q 2021-04-12
Q1 2020 300B* +300B Mar 31, 2020 10-Q 2021-03-29
Q4 2019 300B* 0 Dec 31, 2019 10-K 2021-04-30
Q3 2019 300M +225M +300% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 150M +120M +400% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 75M +45M +150% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 300B* +300B Dec 31, 2018 10-K 2021-03-18
Q3 2018 75M +45M +150% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 30M 0 0% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 30M 0 0% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 75M +45M +150% Dec 31, 2017 10-K 2019-03-29
Q3 2017 30M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 30M 0 0% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 30M 0 0% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 30M 0 0% Dec 31, 2016 10-K 2018-04-02
Q3 2016 30M 0 0% Sep 30, 2016 10-Q 2016-11-15
Q2 2016 30M 0 0% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 30M -170M -85% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 30M 0 0% Dec 31, 2015 10-K 2017-03-22
Q3 2015 30M -70M -70% Sep 30, 2015 10-Q 2015-11-23
Q2 2015 30M -70M -70% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 200M +100M +100% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 30M -170M -85% Dec 31, 2014 10-K 2016-03-30
Q3 2014 100M 0 0% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 100M 0 0% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 100M 0 0% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 200M +100M +100% Dec 31, 2013 10-K 2015-03-31
Q3 2013 100M -1.4B -93.3% Sep 30, 2013 10-Q 2013-11-19
Q2 2013 100M -1.4B -93.3% Jun 30, 2013 10-Q 2013-08-19
Q1 2013 100M -1.4B -93.3% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 100M -1.4B -93.3% Dec 31, 2012 10-K 2014-04-11
Q3 2012 1.5B +700M +87.5% Sep 30, 2012 10-Q 2012-11-05
Q2 2012 1.5B +700M +87.5% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 1.5B +1.3B +650% Mar 31, 2012 10-Q/A 2012-06-01
Q4 2011 1.5B 0 0% Dec 31, 2011 10-K 2013-04-02
Q3 2011 800M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 800M Jun 30, 2011 10-Q/A 2011-09-14
Q1 2011 200M Mar 28, 2011 10-K 2013-04-02
Q4 2010 1.5B Dec 31, 2010 10-K 2012-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.